Aiping Luo
- Cancer Research top 2%
- MicroRNA in disease regulation 8
- Protease and Inhibitor Mechanisms 8
- Cancer-related molecular mechanisms research 6
- Molecular Biology top 5%
- Cancer-related gene regulation 11
- S100 Proteins and Annexins 8
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 6
- Oncology top 5%
- Immunology top 10%
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research 6
- Journals
- Cancer Letters (4 papers)Journal of Biological Chemistry (4 papers)Cancer Research (4 papers)
- Partner nations
- ChinaUnited StatesSouth Africa
In The Last Decade
Aiping Luo
57 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 998
- Molecular Biology 1.8k
- Oncology 598
- Immunology 296
- Immunology and Allergy 70
Countries citing papers authored by Aiping Luo
This map shows the geographic impact of Aiping Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiping Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiping Luo more than expected).
Fields of papers citing papers by Aiping Luo
This network shows the impact of papers produced by Aiping Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiping Luo. The network helps show where Aiping Luo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aiping Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2025 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 22 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2024 | 0 | |
| 13 | 2021 | 9 | |
| 14 | 2020 | 31 | |
| 15 | 2019 | 108 | |
| 16 | 2017 | 32 | |
| 17 | 2012 | 24 | |
| 18 | 2012 | 198 | |
| 19 | 2009 | 36 | |
| 20 | 2006 | 13 |
About Aiping Luo
Aiping Luo is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Immunology and Allergy, having authored 66 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cancer-related gene regulation (11 papers), MicroRNA in disease regulation (8 papers), Protease and Inhibitor Mechanisms (8 papers), S100 Proteins and Annexins (8 papers), RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (6 papers) and Cell Adhesion Molecules Research (6 papers). The work is most often cited by research in Cancer Research (998 citations), Molecular Biology (1.8k citations) and Oncology (598 citations). Aiping Luo has collaborated with scholars based in China, United States and South Africa. Frequent co-authors include Zhihua Liu, Fang Ding, Hongyan Chen, Fang Ding, Yanyan Tian, Yiran Cai, Qin Su, Zhihua Liu, Xuantong Zhou and Xiuqin Wang. Their work appears in journals such as Cancer Letters, Journal of Biological Chemistry, Cancer Research, Advanced Materials and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.